Dwarikesh Sugar Industries Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 28, 2025, 7:55 am

Competitors of Dwarikesh Sugar Industries Ltd

All Competitor Stocks of Dwarikesh Sugar Industries Ltd

Quarterly Result

Last Updated: August 20, 2025, 11:20 am

Below is a detailed analysis of the quarterly data for Dwarikesh Sugar Industries Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 405.47 Cr.. The value appears to be declining and may need further review. It has decreased from 458.85 Cr. (Mar 2025) to 405.47 Cr., marking a decrease of 53.38 Cr..
• For Expenses, as of Jun 2025, the value is 401.55 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 351.87 Cr. (Mar 2025) to 401.55 Cr., marking an increase of 49.68 Cr..
• For Operating Profit, as of Jun 2025, the value is 3.92 Cr.. The value appears to be declining and may need further review. It has decreased from 106.98 Cr. (Mar 2025) to 3.92 Cr., marking a decrease of 103.06 Cr..
• For OPM %, as of Jun 2025, the value is 0.97%. The value appears to be declining and may need further review. It has decreased from 23.31% (Mar 2025) to 0.97%, marking a decrease of 22.34%.
• For Other Income, as of Jun 2025, the value is 0.50 Cr.. The value appears strong and on an upward trend. It has increased from 0.22 Cr. (Mar 2025) to 0.50 Cr., marking an increase of 0.28 Cr..
• For Interest, as of Jun 2025, the value is 5.39 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 7.68 Cr. (Mar 2025) to 5.39 Cr., marking a decrease of 2.29 Cr..
• For Depreciation, as of Jun 2025, the value is 12.06 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 11.89 Cr. (Mar 2025) to 12.06 Cr., marking an increase of 0.17 Cr..
• For Profit before tax, as of Jun 2025, the value is -13.03 Cr.. The value appears to be declining and may need further review. It has decreased from 87.63 Cr. (Mar 2025) to -13.03 Cr., marking a decrease of 100.66 Cr..
• For Tax %, as of Jun 2025, the value is -28.01%. The value appears to be improving (decreasing) as expected. It has decreased from 47.13% (Mar 2025) to -28.01%, marking a decrease of 75.14%.
• For Net Profit, as of Jun 2025, the value is -9.38 Cr.. The value appears to be declining and may need further review. It has decreased from 46.33 Cr. (Mar 2025) to -9.38 Cr., marking a decrease of 55.71 Cr..
• For EPS in Rs, as of Jun 2025, the value is -0.51. The value appears to be declining and may need further review. It has decreased from 2.50 (Mar 2025) to -0.51, marking a decrease of 3.01.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 5:27 am

Growth

Last Updated: September 5, 2025, 3:15 am

Balance Sheet

Last Updated: November 9, 2025, 1:56 pm

Below is a detailed analysis of the balance sheet data for Dwarikesh Sugar Industries Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2025, the value is 19.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 19.00 Cr..
• For Reserves, as of Sep 2025, the value is 736.00 Cr.. The value appears to be declining and may need further review. It has decreased from 788.00 Cr. (Mar 2025) to 736.00 Cr., marking a decrease of 52.00 Cr..
• For Borrowings, as of Sep 2025, the value is 175.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 507.00 Cr. (Mar 2025) to 175.00 Cr., marking a decrease of 332.00 Cr..
• For Other Liabilities, as of Sep 2025, the value is 99.00 Cr.. The value appears to be improving (decreasing). It has decreased from 149.00 Cr. (Mar 2025) to 99.00 Cr., marking a decrease of 50.00 Cr..
• For Total Liabilities, as of Sep 2025, the value is 1,028.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,463.00 Cr. (Mar 2025) to 1,028.00 Cr., marking a decrease of 435.00 Cr..
• For Fixed Assets, as of Sep 2025, the value is 524.00 Cr.. The value appears to be declining and may need further review. It has decreased from 547.00 Cr. (Mar 2025) to 524.00 Cr., marking a decrease of 23.00 Cr..
• For CWIP, as of Sep 2025, the value is 4.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2025) to 4.00 Cr., marking an increase of 4.00 Cr..
• For Investments, as of Sep 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 1.00 Cr..
• For Other Assets, as of Sep 2025, the value is 500.00 Cr.. The value appears to be declining and may need further review. It has decreased from 915.00 Cr. (Mar 2025) to 500.00 Cr., marking a decrease of 415.00 Cr..
• For Total Assets, as of Sep 2025, the value is 1,028.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,463.00 Cr. (Mar 2025) to 1,028.00 Cr., marking a decrease of 435.00 Cr..

Notably, the Reserves (736.00 Cr.) exceed the Borrowings (175.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Dwarikesh Sugar Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 1.26. This value is below the healthy minimum of 5. It has decreased from 4.44 (Mar 24) to 1.26, marking a decrease of 3.18.
• For Diluted EPS (Rs.), as of Mar 25, the value is 1.26. This value is below the healthy minimum of 5. It has decreased from 4.44 (Mar 24) to 1.26, marking a decrease of 3.18.
• For Cash EPS (Rs.), as of Mar 25, the value is 3.90. This value is within the healthy range. It has decreased from 7.22 (Mar 24) to 3.90, marking a decrease of 3.32.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 43.51. It has decreased from 43.66 (Mar 24) to 43.51, marking a decrease of 0.15.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 43.51. It has decreased from 43.66 (Mar 24) to 43.51, marking a decrease of 0.15.
• For Dividend / Share (Rs.), as of Mar 25, the value is 0.50. This value is below the healthy minimum of 1. It has increased from 0.00 (Mar 24) to 0.50, marking an increase of 0.50.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 73.33. It has decreased from 90.79 (Mar 24) to 73.33, marking a decrease of 17.46.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 6.47. This value is within the healthy range. It has decreased from 11.50 (Mar 24) to 6.47, marking a decrease of 5.03.
• For PBIT / Share (Rs.), as of Mar 25, the value is 3.83. This value is within the healthy range. It has decreased from 8.72 (Mar 24) to 3.83, marking a decrease of 4.89.
• For PBT / Share (Rs.), as of Mar 25, the value is 2.83. This value is within the healthy range. It has decreased from 7.65 (Mar 24) to 2.83, marking a decrease of 4.82.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 1.26. This value is below the healthy minimum of 2. It has decreased from 4.44 (Mar 24) to 1.26, marking a decrease of 3.18.
• For PBDIT Margin (%), as of Mar 25, the value is 8.82. This value is below the healthy minimum of 10. It has decreased from 12.67 (Mar 24) to 8.82, marking a decrease of 3.85.
• For PBIT Margin (%), as of Mar 25, the value is 5.22. This value is below the healthy minimum of 10. It has decreased from 9.59 (Mar 24) to 5.22, marking a decrease of 4.37.
• For PBT Margin (%), as of Mar 25, the value is 3.86. This value is below the healthy minimum of 10. It has decreased from 8.42 (Mar 24) to 3.86, marking a decrease of 4.56.
• For Net Profit Margin (%), as of Mar 25, the value is 1.71. This value is below the healthy minimum of 5. It has decreased from 4.88 (Mar 24) to 1.71, marking a decrease of 3.17.
• For Return on Networth / Equity (%), as of Mar 25, the value is 2.89. This value is below the healthy minimum of 15. It has decreased from 10.15 (Mar 24) to 2.89, marking a decrease of 7.26.
• For Return on Capital Employeed (%), as of Mar 25, the value is 7.19. This value is below the healthy minimum of 10. It has decreased from 15.89 (Mar 24) to 7.19, marking a decrease of 8.70.
• For Return On Assets (%), as of Mar 25, the value is 1.59. This value is below the healthy minimum of 5. It has decreased from 5.90 (Mar 24) to 1.59, marking a decrease of 4.31.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.11. This value is below the healthy minimum of 0.2. It has decreased from 0.17 (Mar 24) to 0.11, marking a decrease of 0.06.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.62. This value is within the healthy range. It has increased from 0.54 (Mar 24) to 0.62, marking an increase of 0.08.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.94. It has decreased from 1.27 (Mar 24) to 0.94, marking a decrease of 0.33.
• For Current Ratio (X), as of Mar 25, the value is 1.90. This value is within the healthy range. It has decreased from 2.16 (Mar 24) to 1.90, marking a decrease of 0.26.
• For Quick Ratio (X), as of Mar 25, the value is 0.32. This value is below the healthy minimum of 1. It has increased from 0.21 (Mar 24) to 0.32, marking an increase of 0.11.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.82. This value is below the healthy minimum of 4. It has decreased from 2.19 (Mar 24) to 1.82, marking a decrease of 0.37.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 6.47. This value is within the healthy range. It has decreased from 10.76 (Mar 24) to 6.47, marking a decrease of 4.29.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.26. This value is below the healthy minimum of 3. It has decreased from 5.15 (Mar 24) to 2.26, marking a decrease of 2.89.
• For Enterprise Value (Cr.), as of Mar 25, the value is 1,104.19. It has decreased from 1,725.65 (Mar 24) to 1,104.19, marking a decrease of 621.46.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.81. This value is below the healthy minimum of 1. It has decreased from 1.01 (Mar 24) to 0.81, marking a decrease of 0.20.
• For EV / EBITDA (X), as of Mar 25, the value is 9.21. This value is within the healthy range. It has increased from 7.97 (Mar 24) to 9.21, marking an increase of 1.24.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.50. This value is below the healthy minimum of 1. It has decreased from 0.76 (Mar 24) to 0.50, marking a decrease of 0.26.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Price / BV (X), as of Mar 25, the value is 0.84. This value is below the healthy minimum of 1. It has decreased from 1.59 (Mar 24) to 0.84, marking a decrease of 0.75.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.50. This value is below the healthy minimum of 1. It has decreased from 0.76 (Mar 24) to 0.50, marking a decrease of 0.26.
• For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has decreased from 0.06 (Mar 24) to 0.03, marking a decrease of 0.03.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness